Vanguard Group’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $328K | Buy |
|
|||||
|
2022
Q3 | $569K | Sell |
|
|||||
|
2022
Q2 | $616K | Hold |
|
|||||
|
2022
Q1 | $1.52M | Hold |
|
|||||
|
2021
Q4 | $2.37M | Sell |
|
|||||
|
2021
Q3 | $2.64M | Hold |
|
|||||
|
2021
Q2 | $2.76M | Sell |
|
|||||
|
2021
Q1 | $3.4M | Hold |
|
|||||
|
2020
Q4 | $2.96M | Buy |
|
|||||
|
2020
Q3 | $2.89M | Buy |
|
|||||
|
2020
Q2 | $4.61M | Buy |
|
|||||
|
2020
Q1 | $128K | Buy |
|
|||||
|
2019
Q4 | $45K | Hold |
|
|||||
|
2019
Q3 | $127K | Hold |
|
|||||
|
2019
Q2 | $173K | Buy |
|
|||||
|
2019
Q1 | $86K | Buy |
|
|||||
|
2018
Q4 | $12K | Sell |
|
|||||
|
2018
Q3 | $55K | Sell |
|
|||||
|
2018
Q2 | $184K | Sell |
|
|||||
|
2018
Q1 | $278K | Buy |
|
|||||
|
2017
Q4 | $536K | Hold |
|
|||||
|
2017
Q3 | $950K | Buy |
|
|||||
|
2017
Q2 | $1.05M | Buy |
|
|||||
|
2017
Q1 | $1.49M | Buy |
|
|||||
|
2016
Q4 | $174K | Buy |
|
|||||
|
2016
Q3 | $227K | Buy |
|
|||||
|
2016
Q2 | $273K | Buy |
|
|||||
|
2016
Q1 | $492K | Buy |
|
|||||
|
2015
Q4 | $404K | Buy |
|
|||||
|
2015
Q3 | $633K | Buy |
|
|||||
|
2015
Q2 | $591K | Buy |
|
|||||
|
2015
Q1 | $482K | Buy |
|
|||||
|
2014
Q4 | $73K | Hold |
|
|||||
|
2014
Q3 | $72K | Hold |
|
|||||
|
2014
Q2 | $177K | Hold |
|
|||||
|
2014
Q1 | $205K | Buy |
|